Lv1
80 积分 2026-05-03 加入
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment
1小时前
待确认
PDL1 and IDO ‐2 Immunohistochemistry in Bronchoalveolar Lavage Versus Bronchoscopic Biopsy of Non‐Small Cell Lung Cancer
4小时前
已完结
Tertiary lymphoid structures in anticancer immunity
1个月前
已完结
Future perspectives and challenges for identification and recognition of clinically significant cancer biomarkers
1个月前
已关闭
Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy
1个月前
已完结
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment
1个月前
已完结
Role of Yin Yang 1 (YY1) on microenvironment, signaling pathways, and epigenetics in lung cancer
1个月前
已关闭
Strategies to optimize duration of immunotherapy in advanced NSCLC: Current evidence and future directions
2个月前
已完结
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
2个月前
已完结
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR
2个月前
已完结
皖公网安备34019202002308
